SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-17-004315
Filing Date
2017-03-14
Accepted
2017-03-14 17:15:12
Documents
5
Period of Report
2017-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20170314.htm 8-K 56633
2 EX-4.1 tcon-ex41_8.htm EX-4.1 140235
3 EX-99.1 tcon-ex991_7.htm EX-99.1 290578
4 EX-99.2 tcon-ex992_6.htm EX-99.2 19150
5 GRAPHIC g2017031419185751735912.jpg GRAPHIC 8000
  Complete submission text file 0001564590-17-004315.txt   519117
Mailing Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122
Business Address 8910 UNIVERSITY CENTER DRIVE SUITE 700 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 17688932
SIC: 2836 Biological Products, (No Diagnostic Substances)